Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)

Posted Date: Mar 10, 2025
Mar 14, 2025
Awarded Date: No Awarded Date
SetAside Type
Solicitation ID Solicitation Title Solicitation Office
NOI-CC-25-004297 Piflufolastat F-18 injection drugs (Pylarify) from Sofie Co. (Notice of Intent to sole source)
Synopsis

Acquisition Description:

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with Sofie Co. (a.k.a. Sofie Biosciences Inc.).

The National Institute of Health, Clinical Center (NIH-CC)’s has the Nuclear Pharmacy (CC NP) department (collectively “Program”) that purchases and compounds radiopharmaceuticals (radioactive drugs) on a daily basis for life-saving clinical nuclear medicine procedures. This is essential for the NIH Clinical Center to achieve optimal patient care. These radiopharmaceuticals are United States Food and Drug .... Read More

Office Location Agency Name Solicitation Base Posting Type
NATIONAL INSTITUTES OF HEALTH Presolicitation
An error has occurred. This application may no longer respond until reloaded. Reload 🗙